Glutamine metabolism drives succinate accumulation in plasma and the lung during hemorrhagic shock.
Metabolomic investigations have consistently reported succinate accumulation in plasma after critical injury. Succinate receptors have been identified on numerous tissues, and succinate has been directly implicated in postischemic inflammation, organ dysfunction, platelet activation, and the generation of reactive oxygen species, which may potentiate morbidity and mortality risk to patients. Metabolic flux (heavy-isotope labeling) studies demonstrate that glycolysis is not the primary source of increased plasma succinate during protracted shock. Glutamine is an alternative parent substrate for ATP generation during anaerobic conditions, a biochemical mechanism that ultimately supports cellular survival but produces succinate as a catabolite. We hypothesize that succinate accumulation during hemorrhagic shock is driven by glutaminolysis.



Sprague-Dawley rats were subjected to hemorrhagic shock for 45 minutes (shock, n = 8) and compared with normotensive shams (sham, n = 8). At 15 minutes, animals received intravenous injection of C5-N2-glutamine solution (iLG). Blood, brain, heart, lung, and liver tissues were harvested at defined time points. Labeling distribution in samples was determined by ultrahigh-pressure liquid chromatography-mass spectrometry metabolomic analysis. Repeated-measures analysis of variance with Tukey comparison determined significance of relative fold change in metabolite level from baseline.



Hemorrhagic shock instigated succinate accumulation in plasma and lungs tissues (8.5- vs. 1.1-fold increase plasma succinate level from baseline, shock vs. sham, p = 0.001; 3.2-fold higher succinate level in lung tissue, shock vs. sham, p = 0.006). Metabolomic analysis identified labeled glutamine and labeled succinate in plasma (p = 0.002) and lung tissue (p = 0.013), confirming glutamine as the parent substrate. Kinetic analyses in shams showed constant total levels of all metabolites without significant change due to iLG.



Glutamine metabolism contributes to increased succinate concentration in plasma during hemorrhagic shock. The glutaminolytic pathway is implicated as a therapeutic target to prevent the contribution of succinate accumulation in plasma and the lung-to-postshock pathogenesis.
From the Department of Surgery, University of Colorado Denver, Aurora, Colorado (A.L.S., E.E.M., A.B., C.C.S., M.F. A.W.B., H.B.M., E.D.P.); Department of Biochemistry and Molecular Genetics, University of Colorado Denver, Aurora, Colorado (A.D., K.C.H., J.A.R., M.J.W.); Denver Health Medical Center, Denver, Colorado (E.E.M., M.F.); Department of Pediatrics, University of Colorado Denver, Aurora, Colorado (C.C.S.); and Bonfils Blood Center, Denver, Colorado (C.C.S.).
Anne L
AL
Slaughter
Angelo
A
D'Alessandro
Ernest E
EE
Moore
Anirban
A
Banerjee
Christopher C
CC
Silliman
Kirk C
KC
Hansen
Julie A
JA
Reisz
Miguel
M
Fragoso
Matthew J
MJ
Wither
Anthony W
AW
Bacon
Hunter B
HB
Moore
Erik D
ED
Peltz
D000818:Animals; D001921:Brain / Q000378:metabolism; D004195:Disease Models, Animal; D005973:Glutamine / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012771:Shock, Hemorrhagic / Q000378:metabolism*; D019802:Succinic Acid / Q000378:metabolism*
D005973:Glutamine; D019802:Succinic Acid